EIC Grant Success Rate Drops to Two Percent in 2026
Researchers compete for limited funding as the European Innovation Council selects only 43 projects for support.
Updated on Oct. 26, 2026 in Biotech
Live Poll
Should government innovation grants prioritize projects with a clear path to market?
In 2026, the European Innovation Council selected 43 projects for Pathfinder Open grants from a pool of over 2,000 applicants. This selection process resulted in a 2 percent success rate for researchers seeking funding.
Why it matters
The low grant success rate highlights the extreme competition for early-stage funding in the European research ecosystem, forcing teams to demonstrate a clear path to market to secure support.
The Metacare project aims to provide a diagnostic tool that delivers test results in 30 minutes. The team intends to price the device at $1 per unit.
The players
European Innovation Council
An EU body that provides grant funding and support to research projects with commercial potential.
Francesco Dell'Olio
The coordinator of the Metacare diagnostic project.
The details
Applicants must demonstrate a viable path to market to qualify for Pathfinder funding. The Metacare diagnostic tool, coordinated by Francesco Dell'Olio, is designed to identify sexually transmitted diseases. This research-stage development relies on the ability to produce diagnostic results in under half an hour at a low price point.
Timeline
2025: Metacare submitted an unsuccessful grant application.
2026: The EIC selected 43 projects for funding.
The Tech Race
The EIC Pathfinder program remains a primary funding vehicle for high-risk, high-gain research projects in Europe. Securing these grants serves as a key milestone for teams aiming to bridge the gap between initial scientific research and commercial viability.
Researchers and startups continue to face significant barriers to entry with only 2 percent of applications receiving funding. Those developing diagnostic tools must focus on price and speed, such as the $1 and 30-minute targets established by projects like Metacare.
The takeaway
The extremely low success rate emphasizes that only projects with a highly defined path to market gain approval. Watch for future funding announcements to see if grant thresholds change as the EIC adjusts its portfolio to prioritize commercial scalability.
Further reading
Learn more about advancements in Biotech research and project funding.
Source note: This article includes information reported by Science Business.
Live Poll
Should government innovation grants prioritize projects with a clear path to market?
